Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

J&J halts COVID-19 vaccine study following unidentified participant illness

October 13, 2020 Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
News
800px-who_flag

Head of WHO says herd immunity strategies for COVID-19 are ‘unethical’

October 13, 2020 Manufacturing and Production

Tedros Adhanom Ghebreyesus, Director of the World Health Organization, has warned against pursuing a strategy of herd immunity to fight …
News
bavencio

Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma

October 13, 2020 Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC

The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …
News
800px-covid-19_-_covent_garden_london_uk_during_lockdown

UK Government ignored SAGE advice to impose full lockdown last month

October 13, 2020 Manufacturing and Production COVID, UK, UK Coronavirus, coronavirus

UK Government ministers ignored warnings three weeks ago that the country should go into a temporary full lockdown to reduce …
News

Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

October 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments

BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …
Appointment
david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …
Appointment
800px-eli_lilly_corporate_center_indianapolis_indiana_usa

Eli Lilly’s antibody COVID-19 therapy reduces virus levels and hospitalisations

October 8, 2020 Manufacturing and Production Eli Lilly, FDA

Eli Lilly is seeking Emergency Use Authorization from the FDA after releasing interim data based on early trial results.
News
president_of_the_united_states_donald_j

Regeneron applies for FDA Emergency Use Authorization for COVID-19 antibody treatment given to Trump

October 8, 2020 Manufacturing and Production COVID, Trump, coronavirus

Regeneron has announced that it has applied for an Emergency Use Authorization from the FDA for its experimental antibody therapy …
News
shutterstock_2

Gilead to meet rising remdesivir demand in Europe with new supply deal

October 8, 2020 Manufacturing and Production COVID-19, Europe, Gilead

The European Commission (EC) has signed a new joint procurement agreement (JPA) with pharma firm Gilead to improve access to …
News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

October 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
Appointment
headache

Aimovig reduces frequency of episodic migraines, five-year data reveals

October 6, 2020 Manufacturing and Production, Research and Development Aimovig

Amgen and Novartis have revealed new five-year Phase 2 data during the Migraine Trust Virtual Symposium for their calcitonin gene-related …
News
800px-nhs_nnuh_entrance

NHS warns that UK could face drugs shortages after Brexit stockpile has been used to fight COVID-19

October 6, 2020 Manufacturing and Production

The NHS has warned that hospitals could face shortages of drugs during the second wave of coronavirus due to the …
News
fda2outsideweb

Opdivo/Yervoy combo secures FDA approval for malignant pleural mesothelioma

October 6, 2020 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Yervoy, bristol myers squibb, opdivo

Bristol Myers Squibb’s therapy regimen of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) has secured FDA approval for the first-line …
News
fda_21_4_1

White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine

October 6, 2020 Manufacturing and Production FDA, Trump, Vaccine, coronavirus vaccines

The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure …
News
4353113087_4d19c3a402_b_1

Bristol Myers Squibb agrees $13 billion deal to acquire MyoKardia

October 6, 2020 Manufacturing and Production BSM, FDA, MyoKardia

Bristol Myers Squibb (BMS) is to purchase MyoKardia for $13 billion to boost its heart disease treatments portfolio. The deal …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026